๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

10 recruiting trials

for Chronic Idiopathic Thrombocytopenic Purpura

Special Drug Use-results Survey for Long-term Use (Fostamatinib) NCT06757257n/a1 site๐Ÿ“ Tokyo and Japanese Other Cities Kissei Pharmaceutical Co., Ltd. ยท Tests: fostamatinib A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia NCT07017725Phase 1, Phase 26 sites๐Ÿ“ Tangshan๐Ÿ“ Zhengzhou๐Ÿ“ Nanchang CASI pharmaceuticals, Inc. ยท Tests: CID-103 A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia NCT06948318Phase 3118 sites๐Ÿ“ Hot Springs๐Ÿ“ Los Angeles๐Ÿ“ San Diego Takeda ยท Tests: Mezagitamab Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia NCT06817395n/a1 site๐Ÿ“ Boston Massachusetts General Hospital A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia NCT06722235Phase 3124 sites๐Ÿ“ Hot Springs๐Ÿ“ Los Angeles๐Ÿ“ San Diego Takeda ยท Tests: Mezagitamab, Placebo Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia NCT05338190Phase 31 site๐Ÿ“ Crรฉteil Assistance Publique - Hรดpitaux de Paris ยท Tests: Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with subcutaneous placebo A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) NCT07059000Phase 328 sites๐Ÿ“ Los Angeles๐Ÿ“ Shirley๐Ÿ“ Greenville Kedrion S.p.A. ยท Tests: Kedrion IVIG 10% A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP) NCT07194850Phase 2, Phase 326 sites๐Ÿ“ Bordeaux๐Ÿ“ La Tronche๐Ÿ“ Vandล“uvre-lรจs-Nancy argenx ยท Tests: Efgartigimod IV, Placebo IV Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) NCT06352281Phase 1, Phase 21 site๐Ÿ“ Kunming 920th Hospital of Joint Logistics Support Force of People'sโ€ฆ ยท Tests: CAR-T cells Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia NCT05931718n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico ยท Tests: cytokine essays, NGS, Fecal microbiome, Erythropoietin, Luspatercept
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy